Agenda

Chair – Dr. Dhanunjaya Lakkireddy             Discussant – Dr. Luigi Di Biase and Dr. Andrea Natale

7:10 AM – 7:20 AM                   I am Not an Implanting Physician – Which Patient Do I Send for Consideration of LAA Closure – Dr. Richard Wright

7:20 AM – 7:30 AM                   How Do You Manage a Patient with GI Bleeding – A Gastroenterologist Perspective – Dr. Raj Vuppalanchi

7:30 AM – 7:40 AM                   LAA Exclusion is a Better Strategy Than Oral Anticoagulation for AF Patients with Stroke –Dr. David Thaler

7:40 AM – 7:50 AM                   Sub-Clinical Atrial Fibrillation and Stroke Understanding the Connection – Dr. Andrea Russo

7:50 AM – 8:00 AM                   When Do you Consider LAAO in a Stroke/TIA/ICH Patient with AF? – Dr. Edip Gurol

8:00 AM – 8:10 AM                   Case-Based Learning – LAA Closure with WATCHMAN in a Patient with Multiple Strokes – Dr. Horst Sievert

8:10 AM – 8:30 AM                    In Non-Paroxysmal AF Patient LAA Endocardial Isolation with LAAO is a Better Strategy than LAA Epicardial Exclusion - Dr. Andrea Natale and Dr. Christopher Ellis

8:30 AM - 8:50 AM                     Panel Discussion

8:50 AM – 9:10 AM    Break

Chair – Dr. James Edgerton                       

Discussant – Dr. Jie Cheng and Dr. Moussa Mansour

9:10 AM – 9:20 AM                    Updates on Less Studied LAA Occlusion Devices – An Overview and Relevance (Includes Aegis/Occlutech/Prolipsis/Cardia/Acoredis and More – Dr. Horst Sievert

9:20 AM – 9:30 AM                    Anatomic Considerations for AtriClip – Mini-Thoracotomy/Vats/Open Approach - Dr. Justin Van Meeteren

9:30 AM – 9:50 AM                    AtriClip Recorded Case – Dr. Krzysztof Bartus

9:50 AM – 10:00 AM                    Post-Procedural Management of AtriClip – Pericarditis/Anticoagulation/Imaging - Dr. Basel Ramlawi

10:00 AM – 10:20 AM                 Lambre Recorded Case – Dr. Yawei Xu

10:20 AM – 10:40 AM                WaveCrest Recorded Case – Dr. Andrea Natale

10:40 AM – 11:00 AM                Panel Discussion

Chair – Dr. Jackie Saw                                

Discussant – Dr. Renu Virmani and Dr. Christopher Ellis

11:00 AM – 11:10 AM                Conforma LAA Occlusion Device - Dr. Vivek Reddy

11:10 AM – 11:20 AM                 WATCHMAN Trials Update – Dr. Saibal Kar

11:20 AM – 11:30 AM                 Amplatzer Cardiac Plug Trials Update – Amulet IDE & More - Dr. Dhanunjaya Lakkireddy

11:30 AM – 11:40 AM                AtriClip, LAAOS III, Convergent and More – Treating AF and LAA at the same time – Dr. Felix Yang

11:40 AM – 12:00 AM                Innovations Circle – Three New LAAO Devices will Be Presented - 

12:00 PM – 12:20 PM                Panel Discussion      

12:20 PM – 1:00 PM  Lunch

Chair – Dr. Randall Lee                             

Discussant – Dr. Saibal Kar and Dr. Abdi Rasekh

1:00 PM – 1:10 PM                    Feasibility and Safety of Same Day LAAO and TAVR/TMVR WATCHMAN-TAVR Study and More – Dr. Amar Krishnaswamy

1:10 PM – 1:20 PM                    WATCHMAN vs WATCHMAN FLX – What is Different and Better? – Dr. David Holmes

1:20 PM – 1:30 PM                    What Other Data Does It Take for LAAO Indication Change from II A to I – Dr. Thomas Deering or FDA

1:30 PM – 1:40 PM                    Transitioning LAA Exclusion Technology from Clinical Trials to Market Place – Lessons From the Lariat, WATCHMAN and ACP Experience - Dr. Shephal Doshi

1:40 PM – 1:50 PM                    How to Build A Successful LAA Referral Program – Dr. Vijay Swarup

1:50 PM – 2:00 PM                    Role of Left Atrial Appendage Closure in Valvular Heart Disease and Atrial Fibrillation – Dr. Ajay Naik

2:00 PM – 2:20 PM                    Panel Discussion

2:20 PM – 2:40 PM    Break

Chair – Dr. David Thaler                            

Discussant – Dr. Yoaav Krauthammer and Dr. Carlos Sanchez

2:40 PM – 2:50 PM                    A Pathologist Perspective on The Future of Stroke Prophylaxis, LAA Occluders and Tissue Specific Targets – Dr. Renu Virmani

2:50 PM – 3:00 PM                    AF Ablation, LAAO – Sequentially or Simultaneously and Why? – Dr. Claudio Tondo

3:00 PM – 3:10 PM                    Understanding NOACs in the 21^st Century – Dual/Triple Therapy and Balancing AF and CAD – Dr. Michael Ezekowitz

3:10 PM – 3:20 PM                    My Patient Has an LAA Occluder And Had an Embolic CVA With No Evidence of Device Related Thrombus or Carotid Disease – What Do I Do? – Dr. David Holmes

3:20 PM – 3:30 PM                    Safety of External Cardioversion in Patients with LAA Exclusion – What Do We Know? – Dr. Amin Al-Ahmad

3:30 PM – 3:40 PM                    Economics of LAAO Program – The Organizational Perspective – Dr. Steve Manoukian

3:40 PM – 3:50 PM                    Should LAA Exclusion be Performed Routinely in Patients that are High Risk for AF During Open Heart Surgery? – Dr. James Edgerton

3:50 PM – 4:10 PM                    Panel Discussion

Chair – Dr. David Holmes    

Discussant – Dr. Moussa Mansour and Dr. David Wilber

4:10 PM – 5:20 PM                    My Most Challenging Cases –

                                                Dr. Apostols Tzikas

                                                Dr. Luigi Di Biase

 5:20 PM                                   Adjourn/Remarks

Chair – Dr. David Holmes Jr.                        

Discussant – Dr. Moussa Mansourand Dr. David Wilber

4:10 PM – 5:00 PM

My Most Challenging Cases

5:00 PM

Adjourn/Remarks